CW-3308, CAS [[3055592-99-6]]

Produktübersicht

• Artikelname: CW-3308, CAS [[3055592-99-6]]
• Artikelnummer: MCE-HY-159579
• Hersteller Artikelnummer: HY-159579
• Alternativnummer: MCE-HY-159579-5MG,MCE-HY-159579-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

CW-3308 is an orally effective PROTAC that selectively targets BRD9 and is expected to be used to inhibit synovial sarcoma, rhabdomyoma, and other BRD9-dependent human diseases. CW-3308 is composed of PROTAC target protein ligand Naphthyridin-Me-dimethoxybenzene-COOH (HY-159596) (red part), Linker 3-Azaspiro[5.5]undecane-9-methanol (HY-159598) (black part), E3 ubiquitin ligase ligand Thalidomide-methylpyrrolidine (HY-159597) (blue part), where the conjugate of E3 ubiquitin ligase ligand + linker is Thalidomide-pyrrolidine-C-azaspiro (HY-159599)[1].

Produkteigenschaften

• Molekulargewicht: 800.90
• Reinheit: 97.08
• CAS Nummer: [3055592-99-6]
• Formel: C45H48N6O8
• Target-Kategorie: Epigenetic Reader Domain,PROTACs

Anwendungsbeschreibung

• Anwendungsbeschreibung: Reference compound